Table 1 Samples used for training and evaluating the segmentation model

TCGA-A2-A3XS-01Z-00-DX1

3

×40

0.2456

Breast, Infiltrating ductal carcinoma

Train

TCGA-XF-AAMJ-01Z-00-DX1

2

×40

0.2527

Bladder, Urothelial carcinoma

Train

TCGA-UW-A72Q-01Z-00-DX1

3

×40

0.2472

Liver, Hepatocellular carcinoma

Train

TCGA-G3-A7M6-01Z-00-DX1

2

×40

0.2527

Liver, Hepatocellular carcinoma

Train

TCGA-KM-A7QL-01Z-00-DX1

1

×40

0.2525

Kidney, Renal cell carcinoma

Train

TCGA-CV-A6JD-01Z-00-DX1

1

×40

0.2527

Head and neck squamous cell carcinoma

Train

TCGA-02-0009-01Z-00-DX1

1

×20

0.5015

Brain, Glioblastoma

Train

TCGA-LB-A8F3-01Z-00-DX1

3

×40

0.2527

Pancreas, Pancreatic adenocarcinoma

Train

TCGA-36-2547-01A-01-TS1

1

×20

0.5015

Ovary, Ovarian serous cystadenocarcinoma

Train

TCGA-W5-AA30-01Z-00-DX1

3

×40

0.2529

Bile duct, Cholangiocarcinoma

Train

TCGA-86-7701-01Z-00-DX1

2

×40

0.252

Lung, Lung adenocarcinoma

Train

TCGA-B0-4823-01Z-00-DX1

3

×40

0.252

Kidney, Renal clear cell carcinoma

Train

TCGA-02-0009-01Z-00-DX1

1

×20

0.5015

Brain, Glioblastoma multiforme

Train

TCGA-2G-AAKO-05Z-00-DX1

1

×40

0.2277

Testicle, Acute myeloid leukemia

Train

PathAI

3

×40

0.2511

Liver, Hepatitis B

Train

PathAI

3

×40

0.2522

Liver, Non-alcoholic steatohepatitis

Train

PathAI

3

×40

0.2522

Kidney, Lupus

Train

PathAI

1

×40

0.2522

Colon, Inflammatory Bowel disease

Train

PathAI

2

×20

0.5023

Small intestine, Carcinoid

Train

PathAI

1

×40

0.2522

Prostate, Prostate adenocarcinoma

Train

TCGA-EJ-5495-01Z-00-DX1

2

×40

0.252

Prostate, Prostate adenocarcinoma

Validation

TCGA-IG-A3YA-01Z-00-DX1

2

×40

0.2465

Esophagus, Esophageal carcinoma

Validation

TCGA-GS-A9U3-01Z-00-DX1

2

×40

0.2525

Lymph, Diffuse large B cell lymphoma

Validation

TCGA-LL-A5YM-01Z-00-DX1

2

×40

0.2456

Breast, Invasive ductal carcinoma

Validation

TCGA-P4-AAVO-01Z-00-DX1

3

×40

0.2526

Kidney, Renal papillary cell carcinoma

Validation

PathAI

2

×40

0.2522

Liver, Non-alcoholic steatohepatitis

Validation

PathAI

1

×20

0.5023

Colon, Human papillomavirus

Validation

PathAI

2

×40

0.2511

Brain, Glioma

Validation

PathAI

2

×40

0.2522

Skin, Normal

Validation

TCGA-VQ-A8DV-01Z-00-DX1

1

×40

0.2525

Stomach, Stomach adenocarcinoma

Test

TCGA-CV-6934-01Z-00-DX1

2

×40

0.2525

Head and neck squamous cell carcinoma

Test

TCGA-MQ-A6BR-01Z-00-DX1

1

×40

0.2465

Lung, Mesothelioma

Test

TCGA-OR-A5J8-01Z-00-DX1

1

×40

0.2527

Adrenal, Adrenal cortical carcinoma

Test

PathAI

1

×40

0.2522

Colon, Inflammatory Bowel disease

Test

PathAI

1

×20

0.5023

Breast, Invasive ductal carcinoma

Test

PathAI

2

×40

0.2522

Prostate, Prostate adenocarcinoma

Test